Zacks Small Cap Research – MIRA Continues to Post Outstanding Test Results – Go Health Pro

By Brad Sorensen, CFA NASDAQ:MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic cannabinoid analog for the treatment of adult patients with neuropathic pain as well as anxiety and cognitive decline typically associated with early-stage dementia. The company … Read more

Zacks Small Cap Research – BSEM Announces Expanding Market and Stellar Test Results – Go Health Pro

By Brad Sorensen, CFA OTC:BSEM READ THE FULL BSEM RESEARCH REPORT BioStem Technologies, Inc. (OTC:BSEM) is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The company states its mission is “to discover, develop and produce the most effective regenerative medicine … Read more

Triple-I Blog | Personal Lines Underwriting Results Improve, Reducing Gap With Commercial Lines – Go Health Pro

The U.S. property and casualty insurance industry experienced better-than-expected economic and underwriting results in the first half of 2024, according to the latest forecasting report by Triple-I and Milliman.  The report was released during a members-only webinar on Oct. 10. The industry’s estimated net combined ratio of 99.4 represented a 2.3-points year-over-year improvement, with commercial lines … Read more

Zacks Small Cap Research – AI from EVAX Improves Trial Results – Go Health Pro

By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company’s AI models, novel targets within … Read more

Zacks Small Cap Research – FMST: Foremost Enters Uranium Space Through Option Agreement to Acquire up to 70% Interest in 10 Denison Properties; Spin-Out of Winston Gold/Silver Properties; Results of Winter Drilling Program at Zoro Property. – Go Health Pro

Zacks Small Cap Research – FMST: Foremost Enters Uranium Space Through Option Agreement to Acquire up to 70% Interest in 10 Denison Properties; Spin-Out of Winston Gold/Silver Properties; Results of Winter Drilling Program at Zoro Property. – Go Health Pro

By Steven Ralston, CFA NASDAQ:FMST | CSE:FAT READ THE FULL FMST RESEARCH REPORT FOREMOST ENTERS THE URANIUM INDUSTRY Foremost Enters the Uranium Exploration Industry Through an Option Agreement with Denison On September 24, 2024, Foremost Lithium (NASDAQ:FMST) (CSE:FAT) announced the signing of an Option Agreement with Denison Mines Corp. (NYSE:DNN (TSX:DML) concerning 10 Uranium Exploration … Read more